Recent study has confirmed that nerve growth factor (NGF) bound PBCA nanoparticles (Kurakhmaeva et al., 2009) and L-Dopa encapsulated nanoparticles cross BBB and alleviate basic symptoms of PD (Mohanraj et al., 2013). Here, NGF is linked to Parkinson disease.